Keep the actual comparator visible
The displayed enclomiphene paper describes two randomized studies in overweight men with secondary hypogonadism. It compared oral enclomiphene with testosterone gel and measured testosterone, LH, FSH and sperm concentration over sixteen weeks.
The testosterone comparator was a gel. The current catalog separately lists a cream and testosterone cypionate injections. Keeping the trial preparation visible prevents those products from being silently substituted for the studied comparator.
Sources: PMID 26496621
Laboratory and clinical outcomes answer different questions
An increase in a laboratory value is a defined biochemical outcome. A change in sperm concentration is another outcome, and a reported symptom change is another. A useful research comparison retains each measure and its observation period.
The enclomiphene study reports changes in testosterone and gonadotropins and a difference in sperm-concentration patterns between interventions. Those findings belong to the participants, regimens and sixteen-week period studied. They do not establish every longer-term outcome for every hormone product.
Sources: PMID 26496621
Compare route and administered quantity separately
The testosterone cream lists several concentrations in mg/mL. The testosterone cypionate injection lists 200 mg/mL. A concentration describes an amount per volume of preparation; the administered quantity also depends on the amount of preparation used.
The formulation network below connects each current product to its ingredient record. It keeps the catalog identity beside the literature so preparation, route and outcome can be compared directly.
The formulation network
Each row connects a current product to the ingredient research behind its listed formulation.
Read the source studies
Research synthesis by HealthRX.com, October 5, 2026. The cited sources and linked ingredient pages describe the scope of this comparison.